Hard-to-heal wounds do not heal spontaneously and need long-term care provided by specialists. That burdens the patients as well as the healthcare systems. Such wounds arise from several pathologies, which result in venous leg ulcers (VLU), diabetic foot ulcers (DFU), pressure ulcers (PU), or ulcers originating from post-surgical wounds (pSW). Given the complex nature of hard-to-heal wounds, novel treatments are sought to enable wound healing. We tested the clinical efficacy and applicability of fluid comprising hyaluronic acid and iodine complex (HA-I) in the treatment of hard-to-heal wounds. Patients (n = 56) with VLU, DFU, PU, or pSW hospitalised in multiple wound-care centres in the Czech Republic were treated with HA-I. Wound size, classically visible signs of infection, exudation, pain, and wound bed appearance were monitored for 12 weeks. The highest healing rate was in DFU (71.4%), followed by pSW (62.5%), VLU (55.6%), and PU (44.4%). Classical visible signs of infection were resolved within 8 weeks in all types of wounds. Wound bed appearance improved most noticeably in pSW and then in VLU. Exudation was lowered most significantly in DFU and pSW. The highest decrease in pain was in pSW and DFU. The treatment with HA-I successfully led to either complete closure or significant improvement in the wound's healing. Therefore, the complex of hyaluronic acid and iodine is suitable for the treatment of hard-to-heal wounds of various aetiologies.

Hospital in Ústí nad Orlicí 56218 Ústí nad Orlicí Czech Republic

Long Term Care Facility Albertinum Žamberk 56401 Žamberk Czech Republic

Medical Faculty Masaryk University in Brno 62500 Brno Czech Republic

Vsetín Hospital 75501 Vsetín Czech Republic

Zobrazit více v PubMed

Wilkinson H.N., Hardman M.J. Wound healing: Cellular mechanisms and pathological outcomes. Open Biol. 2020;10:200223. doi: 10.1098/rsob.200223. PubMed DOI PMC

Boateng J., Catanzano O. Advanced Therapeutic Dressings for Effective Wound Healing—A Review. J. Pharm. Sci. 2015;104:3653–3680. doi: 10.1002/jps.24610. PubMed DOI

Žádníková P., Šínová R., Pavlík V., Šimek M., Šafránková B., Hermannová M., Nešporová K., Velebný V. The Degradation of Hyaluronan in the Skin. Biomolecules. 2022;12:251. doi: 10.3390/biom12020251. PubMed DOI PMC

Aya K.L., Stern R. Hyaluronan in Wound Healing: Rediscovering a Major Player. Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc. 2014;22:579–593. doi: 10.1111/wrr.12214. PubMed DOI

Petrey A.C., de la Motte C.A. Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation. Matrix Biol. 2019;78–79:314–323. doi: 10.1016/j.matbio.2018.03.011. PubMed DOI PMC

Petrey A.C., De La Motte C.A. Hyaluronan, a Crucial Regulator of Inflammation. Front. Immunol. 2014;5:101. doi: 10.3389/fimmu.2014.00101. PubMed DOI PMC

King I.C., Sorooshian P. Hyaluronan in skin wound healing: Therapeutic applications. J. Wound Care. 2020;29:782–787. doi: 10.12968/jowc.2020.29.12.782. PubMed DOI

Humbert P., Mikosinki J., Benchikhi H., Allaert F.-A. Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: A double-blind, randomised, controlled trial. Int. Wound J. 2012;10:159–166. doi: 10.1111/j.1742-481X.2012.00957.x. PubMed DOI PMC

Ramos-Torrecillas J., García-Martínez O., De Luna-Bertos E., Ocaña-Peinado F.M., Ruiz C. Effectiveness of Platelet-Rich Plasma and Hyaluronic Acid for the Treatment and Care of Pressure Ulcers. Biol. Res. Nurs. 2014;17:152–158. doi: 10.1177/1099800414535840. PubMed DOI

Kirketerp-Møller K., Stewart P.S., Bjarnsholt T. The zone model: A conceptual model for understanding the microenvironment of chronic wound infection. Wound Repair Regen. 2020;28:593–599. doi: 10.1111/wrr.12841. PubMed DOI PMC

Davies J. Selections in Pathology and Surgery. Longman, Orme, Brown, Green and Longmans; London, UK: 1839.

Maillard J.-Y. Bacterial resistance to biocides in the healthcare environment: Should it be of genuine concern? J. Hosp. Infect. 2007;65:60–72. doi: 10.1016/S0195-6701(07)60018-8. PubMed DOI

Lachapelle J.-M., Castel O., Casado A.F., Leroy B., Micali G., Tennstedt D., Lambert J. Antiseptics in the era of bacterial resistance: A focus on povidone iodine. Clin. Pract. 2013;10:579–592. doi: 10.2217/cpr.13.50. DOI

Gottardi W. The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine. J. Hosp. Infect. 1985;6:1–11. doi: 10.1016/S0195-6701(85)80040-2. PubMed DOI

Brett D. Cadexomer iodine: A fresh look at an old gem. Wound Pract. Res. 2019;27:42–48. doi: 10.33235/wpr.27.1.42-48. DOI

Frankova J., Kubala L., Velebny V., Ciz M., Lojek A. The effect of hyaluronan combined with KI3 complex (Hyiodine wound dressing) on keratinocytes and immune cells. J. Mater. Sci. Mater. Med. 2006;17:891–898. doi: 10.1007/s10856-006-0179-6. PubMed DOI

Slavkovsky R., Kohlerova R., Jiroutova A., Hajzlerova M., Sobotka L., Cermakova E., Kanta J. Effects of hyaluronan and iodine on wound contraction and granulation tissue formation in rat skin wounds. Clin. Exp. Dermatol. 2010;35:373–379. doi: 10.1111/j.1365-2230.2009.03559.x. PubMed DOI

Laznicek M., Svik K., Laznickova A., Velebny V. Preclinical evaluation of wound treatment with hyaluronan-iodine hydrogel. Wounds. 2012;24:267–274. PubMed

Sobotka L., Smahelova A., Pastorova J., Kusalova M. A Case Report of the Treatment of Diabetic Foot Ulcers Using a Sodium Hyaluronate and Iodine Complex. Int. J. Low. Extrem. Wounds. 2007;6:143–147. doi: 10.1177/1534734607304684. PubMed DOI

Sobotka L., Manak J., Vyroubal P., Mottl R., Bláha V., Slemrova M., Chobola M. Successful Treatment of Surgical Abdominal Wounds Complicated by Multiple Bowel Fistulas with a Combination of Total Parenteral Nutrition, Hyaluronan-Iodine Complex and Delayed Surgery: Results of a Monocentric Experience. Nutr. Ther. Metab. 2008;26:177–183.

Sobotka L., Velebný V., Růžičková J., Šlemrová M., Zadák Z. Hyaluronan—Structure, Metabolism, Biological Activities, Therapeutic Applications. Matrix Biology Institute; Edgewater, NJ, USA: 2005. Sodium Hyaluronate with an Jodide Complex in the Treatment of Different Wounds; pp. 847–849.

Oberreiter M., Plodr M., Pavlík V. The Efficacy of Hyaluronic Acid in Combination with an Antiseptic—Experience from Acute Military-Based Wound Care. Worldw. Mil. Med. ALMANAC. 2021;6

Lantis J., Lullove E., Liden B., McEneaney P., Raphael A., Klein R., Winters C., Huynh R. Final Efficacy and Cost Analysis of a Fish Skin Graft vs Standard of Care in the Management of Chronic Diabetic Foot Ulcers: A Prospective, Multicenter, Randomized Controlled Clinical Trial. Wounds. 2023;35:71–79. doi: 10.25270/wnds/22094. PubMed DOI

Rastogi A., Kulkarni S.A., Agarwal S., Akhtar M., Arsule S., Bhamre S., Bhosle D., Desai S., Deshmukh M., Giriraja K.V., et al. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial. JAMA Netw. Open. 2023;6:e2311509. doi: 10.1001/jamanetworkopen.2023.11509. PubMed DOI

Della Pepa G., Lombardi G., Gianfrancesco S., Piccolo R., Chirico G., Pellegrino M., Santella L., Tecce N., Volpicelli A., Sollo E., et al. Triticum vulgare Extract and Polyhexanide (Fitostimoline® Hydrogel/Fitostimoline® Plus Gauze) versus Saline Gauze Dressing in Patients with Diabetic Foot Ulcers: Results of a Randomized Controlled Trial. J. Clin. Med. 2023;12:3596. doi: 10.3390/jcm12103596. PubMed DOI PMC

Berezo M.L., Budman J., Deutscher D., Hess C.T., Smith K., Hayes D. Predicting Chronic Wound Healing Time Using Machine Learning. Adv. Wound Care. 2022;11:281–296. doi: 10.1089/wound.2021.0073. DOI

Lafontaine N., Jolley J., Kyi M., King S., Iacobaccio L., Staunton E., Wilson B., Seymour C., Rogasch S., Wraight P. Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers. Diabetologia. 2023;66:768–776. doi: 10.1007/s00125-022-05855-7. PubMed DOI

A Michaels J., Campbell B., King B., Palfreyman S.J., Shackley P., Stevenson M. Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial) Br. J. Surg. 2009;96:1147–1156. doi: 10.1002/bjs.6786. PubMed DOI

Serena T.E., Orgill D.P., Armstrong D.G.D., Galiano R.D., Glat P.M., Carter M.J., Kaufman J.P., Li W.W., Zelen C.M.D. A Multicenter, Randomized, Controlled, Clinical Trial Evaluating Dehydrated Human Amniotic Membrane in the Treatment of Venous Leg Ulcers. Plast. Reconstr. Surg. 2022;150:1128–1136. doi: 10.1097/PRS.0000000000009650. PubMed DOI PMC

Mościcka P., Cwajda-Białasik J., Szewczyk M.T., Jawień A. Healing Process, Pain, and Health-Related Quality of Life in Patients with Venous Leg Ulcers Treated with Fish Collagen Gel: A 12-Week Randomized Single-Center Study. Int. J. Environ. Res. Public Health. 2022;19:7108. doi: 10.3390/ijerph19127108. PubMed DOI PMC

Elsharnoby A.M., El-Barbary A.H., Eldeeb A.E., Hassan H.A. Resistant Chronic Venous Leg Ulcers: Effect of Adjuvant Systemic Hyperbaric Oxygen Therapy Versus Venous Intervention Alone. Int. J. Low. Extrem. Wounds. 2022:15347346221100892. doi: 10.1177/15347346221100891. PubMed DOI

Bianchi C., Cazzell S., Vayser D., Reyzelman A.M., Dosluoglu H., Tovmassian G. EpiFix VLU Study Group A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix®) allograft for the treatment of venous leg ulcers. Int. Wound J. 2017;15:114–122. doi: 10.1111/iwj.12843. PubMed DOI PMC

Miller C.N., Newall N., Kapp S.E., Lewin G., Karimi L., Carville K., Gliddon T., Santamaria N.M. A randomized-controlled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers. Wound Repair Regen. 2010;18:359–367. doi: 10.1111/j.1524-475X.2010.00603.x. PubMed DOI

Holloway G., Johansen K.H., Barnes R.W., Pierce G.E. Multicenter trial of cadexomer iodine to treat venous stasis ulcer. West. J. Med. 1989;151:35–38. PubMed PMC

Takahashi J., Nakae K., Miyagawa M., Yokota O., Fujiki Y., Ide M., Sumio, Nishida, Aoki H., Aoki T. Plastic Wrap as a Dressing Material to Treat Stage III/IV Pressure Ulcers in the Inflammatory Phase: A Randomized Controlled Trial. Int. J. Clin. Exp. Med. 2017;10:5586–5594.

Brown-Etris M., Milne C.T., Hodde J.P. An extracellular matrix graft (Oasis® wound matrix) for treating full-thickness pressure ulcers: A randomized clinical trial. J. Tissue Viability. 2018;28:21–26. doi: 10.1016/j.jtv.2018.11.001. PubMed DOI

Tolg C., Telmer P., Turley E. Specific Sizes of Hyaluronan Oligosaccharides Stimulate Fibroblast Migration and Excisional Wound Repair. PLoS ONE. 2014;9:e88479. doi: 10.1371/journal.pone.0088479. PubMed DOI PMC

Shatirishvili M., Burk A.S., Franz C.M., Pace G., Kastilan T., Breuhahn K., Hinterseer E., Dierich A., Bakiri L., Wagner E.F., et al. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress. Cell Death Dis. 2016;7:e2461. doi: 10.1038/cddis.2016.342. PubMed DOI PMC

Pavlík V., Sojka M., Mazúrová M., Velebný V. Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents. PLoS ONE. 2019;14:e0211055. doi: 10.1371/journal.pone.0211055. PubMed DOI PMC